Learn more

ASTELLAS INST FOR REGENERATIVE MEDICINE

Overview
  • Total Patents
    175
  • GoodIP Patent Rank
    13,558
  • Filing trend
    ⇩ 7.0%
About

ASTELLAS INST FOR REGENERATIVE MEDICINE has a total of 175 patent applications. It decreased the IP activity by 7.0%. Its first patent ever was published in 2005. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are PHIO PHARMACEUTICALS CORP, TIANJIN JIMINGSHENG BIOLOG TECHNOLOGY CO LTD and SMITH JAMES JEFFERSON.

Patent filings per year

Chart showing ASTELLAS INST FOR REGENERATIVE MEDICINEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lanza Robert 68
#2 Lu Shi-Jiang 47
#3 Lanza Robert P 33
#4 Klimanskaya Irina V 28
#5 Gay Roger 28
#6 Klimanskaya Irina 19
#7 Wang Wei 18
#8 Chu Jianlin 14
#9 Kimbrel Erin Anne 13
#10 Kouris Nicholas Arthur 13

Latest patents

Publication Filing date Title
WO2021041591A1 Compositions and methods of treating vascular diseases
WO2021041592A1 Methods of treating vascular diseases
US2019282622A1 Modalities for the treatment of degenerative diseases of the retina
AU2016250484A1 Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogammed cells
AU2016250412A1 Derivation of Embryonic Stem Cells and Embryo-Derived Cells
CA2995977A1 Clinical formulations
KR20180011761A An improved assay for the efficacy of human retinal pigment epithelial (RPE) cells and photoreceptor precursor cells
SG11201701709YA Retinal ganglion cells and progenitors thereof
AU2015201435A1 Improved methods of producing RPE cells and compositions of RPE cells
AU2014203668A1 Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogammed cells
AU2014233403A1 Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
AU2014201421A1 Derivation of Embryonic Stem Cells and Embryo-Derived Cells
AU2013267025A1 Improved modalities for the treatment of degenerative diseases of the retina
AU2013201444A1 Hemangio-colony forming cells
EP2788472A2 Method of directed differentiation producing corneal endothelial cells
AU2012201562A1 Improved modalities for the treatment of degenerative diseases of the retina
AU2011280878B2 Methods for detection of rare subpopulations of cells and highly purified compositions of cells
EP3441462A1 Hemangio colony forming cells and non-engrafting hemangio cells
EP2302034A2 Improved methods of reprogramming animal somatic cells